Status: Recruiting
Allergy Delabeling in Antibiotic Stewardship - Intervention
The overall goal of the RENEW-IN intervention is to assess the impact of a BL allergy delabeling intervention on antibiotic use and clinical outcomes in patients with a hematologic malignancy.
Participants needed: 3,800
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Abramson Cancer Center at Penn MedicineUpdated: Jun 17, 2026Locations: 1
Eligibility criteria
all patients with a hematologic malignancy (including Hodgkin and non-Hodgkin ly... [+1]
patients with a history of severe cutaneous adverse reaction [+5]